West Coast Clinical Trials Opens Second Facility In Costa Mesa, California
West Coast Clinical Trials (WCCT) has announced the opening of a new 30 bed, 11,000 sq. ft. facility in Costa Mesa, California.

CYPRESS, CA, March 13, 2010 /24-7PressRelease/ -- The new unit will enable WCCT to house additional clinical research participants, and expand their base of operations.

Dr. Tom Pillsworth, Vice President of Business Development has stated, "The new unit has been designed specifically for the continued strong interest by sponsors in conducting phase I studies in special populations. Specifically, given our recent conduct of multiple phase I pediatric trials (asthma, ADHD, GERD, allergic rhinitis, etc.) as a single site and continued interest in this study type, the Costa Mesa facility allows for these studies to be run apart from other adult population studies we currently have planned. It also is perfect for some of the special populations that are being requested by sponsors including: COPD, renally-impaired, Parkinson's Disease, cystic fibrosis, Alzheimer's Disease, etc.

WCCT has a unique focus on Ethno-bridging studies including Japanese bridging/population trials. In addition, WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Renal, Serial ECGs, and Vaccines.

Press Release Contact Information:

Trent Lapinski
West Coast Clinical Trials WCCT
SEO and SEM Specialist
5630 Cerritos Avenue
Cypress, California
USA 90630
Voice: (714) 252-0700
Website: Visit Our Website